Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies - Approches génétiques intégrées et nouvelles thérapies pour les maladies rares Accéder directement au contenu
Article Dans Une Revue Biomedicines Année : 2022

Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies

Résumé

Limb girdle muscular dystrophies (LGMD), caused by mutations in 29 different genes, are the fourth most prevalent group of genetic muscle diseases. Although the link between LGMD and its genetic origins has been determined, LGMD still represent an unmet medical need. Here, we describe a platform for modeling LGMD based on the use of human induced pluripotent stem cells (hiPSC). Thanks to the self-renewing and pluripotency properties of hiPSC, this platform provides a renewable and an alternative source of skeletal muscle cells (skMC) to primary, immortalized, or overexpressing cells. We report that skMC derived from hiPSC express the majority of the genes and proteins that cause LGMD. As a proof of concept, we demonstrate the importance of this cellular model for studying LGMDR9 by evaluating disease-specific phenotypes in skMC derived from hiPSC obtained from four patients.
Fichier principal
Vignette du fichier
biomedicines-10-01428.pdf (3.26 Mo) Télécharger le fichier
Origine : Publication financée par une institution

Dates et versions

hal-03858917 , version 1 (17-11-2022)

Identifiants

Citer

Celine Bruge, Marine Geoffroy, Manon Benabides, Emilie Pellier, Evelyne Gicquel, et al.. Skeletal Muscle Cells Derived from Induced Pluripotent Stem Cells: A Platform for Limb Girdle Muscular Dystrophies. Biomedicines, 2022, 10 (6), pp.1428. ⟨10.3390/biomedicines10061428⟩. ⟨hal-03858917⟩
55 Consultations
112 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More